Literature DB >> 25930982

Substance use and its impact on care outcomes among HIV-infected individuals in Manitoba.

Adam Erickson1, Marissa Becker2, Souradet Shaw3, Ken Kasper4, Yoav Keynan4.   

Abstract

The high prevalence of substance use among HIV-infected individuals creates numerous challenges to patient care. This study was undertaken in order to understand the impact of substance use on care outcomes for HIV-infected individuals in Manitoba. Clinical records of 564 HIV-infected individuals in care at Health Sciences Centre in Winnipeg, Manitoba were reviewed. Clinical data were extracted from patient charts for substance users (illicit substance users, alcohol abusers and chronic users of opioids or benzodiazepines) and non-users. Substance users and non-users were analysed using chi-square analysis and logistic regression models to compare basic socio-demographic and clinic variables. Chi-square and analysis of variance were used to compare a subset of substance users based on similar socio-demographic and clinical characteristics. Among HIV-infected individuals in Manitoba, 38% were substance users with over-representation by Aboriginals, females, young adults and residents of Winnipeg's core areas. Opioids and benzodiazepines were the most commonly used substances with the majority of substance users having used multiple classes of substances in their lifetime. Substance users were more likely than non-users to have missed clinic appointments. Among substance users, missed appointments were more common among those who self-identified as Aboriginal, female, young adults, residents of Winnipeg's core areas, heterosexuals and those who had abused alcohol or cocaine/crack. Aboriginal substance users were also less likely to achieve viral load suppression compared to non-Aboriginal substance users. With the high prevalence of substance use among HIV-infected individuals in Manitoba, it is important to identify at-risk individuals in order to implement appropriate care strategies and improve treatment adherence and health outcomes.

Entities:  

Keywords:  AIDS; HIV; Manitoba; care outcomes; epidemiology; substance use

Mesh:

Year:  2015        PMID: 25930982     DOI: 10.1080/09540121.2015.1035634

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  6 in total

Review 1.  Benzodiazepine Use, Misuse, and Harm at the Population Level in Canada: A Comprehensive Narrative Review of Data and Developments Since 1995.

Authors:  Yoko Murphy; Emily Wilson; Elliot M Goldner; Benedikt Fischer
Journal:  Clin Drug Investig       Date:  2016-07       Impact factor: 2.859

2.  Engagement in Maximally-Assisted Therapy and Adherence to Antiretroviral Therapy Among a Cohort of Indigenous People Who Use Illicit Drugs.

Authors:  Brittany Barker; Evan Adams; Evan Wood; Thomas Kerr; Kora DeBeck; Huiru Dong; Jean Shoveller; Julio Montaner; M-J Milloy
Journal:  AIDS Behav       Date:  2019-05

3.  Predictors for Poor Linkage to Care Among Hospitalized Persons Living with HIV and Co-Occurring Substance Use Disorder.

Authors:  Nathan A Summers; Jonathan A Colasanti; Daniel J Feaster; Wendy S Armstrong; Allan Rodriguez; Mamta K Jain; Petra Jacobs; Lisa R Metsch; Carlos Del Rio
Journal:  AIDS Res Hum Retroviruses       Date:  2020-03-03       Impact factor: 2.205

4.  HIV Patients' Preference for Integrated Models of Addiction and HIV Treatment in Vietnam.

Authors:  Diep Nguyen Bich; P Todd Korthuis; Trang Nguyen Thu; Hoa Van Dinh; Giang Le Minh
Journal:  J Subst Abuse Treat       Date:  2016-07-19

Review 5.  HIV-1 and drug abuse comorbidity: Lessons learned from the animal models of NeuroHIV.

Authors:  Susmita Sil; Annadurai Thangaraj; Ernest T Chivero; Fang Niu; Muthukumar Kannan; Ke Liao; Peter S Silverstein; Palsamy Periyasamy; Shilpa Buch
Journal:  Neurosci Lett       Date:  2021-03-29       Impact factor: 3.197

6.  Eligibility for heroin-assisted treatment (HAT) among people who inject opioids and are living with HIV in a Canadian setting.

Authors:  Jan Klimas; Huiru Dong; Nadia Fairbairn; Eugenia Socías; Rolando Barrios; Evan Wood; Thomas Kerr; Julio Montaner; M-J Milloy
Journal:  Addict Sci Clin Pract       Date:  2018-02-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.